| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/30/2013 | CN102895335A Preparation technology and production method for integrated new formulation of radix aconiti lateralis preparata powder |
| 01/30/2013 | CN102895328A Traditional Chinese medicine composition for treating feline and canine urocystitis |
| 01/30/2013 | CN102895319A Composition containing desert cistanche, cynomorium or medlar, pumpkin seeds and pollen |
| 01/30/2013 | CN102895298A Preparation technology and production method for integrated new formulation of Chinese sage herb decoction |
| 01/30/2013 | CN102895297A Preparation technology and production method for integrated new formulation of radix stephaniae tetrandrae and radix astragali decoction |
| 01/30/2013 | CN102895259A Adenosine disodium triphosphate magnesium chloride compound-containing pharmaceutical composition |
| 01/30/2013 | CN102895242A Application of Gypensapogenin B in drugs for treating acute renal failure |
| 01/30/2013 | CN102358879B Formula and production method of body strengthening and health care vinegar |
| 01/30/2013 | CN102151284B Composition containing fucoidin sulfate and application thereof |
| 01/30/2013 | CN102048679B Transdermal preparation containing silodosin, preparation method and medicinal application thereof |
| 01/30/2013 | CN101896477B The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof |
| 01/30/2013 | CN101879156B Medicinal composition and application thereof |
| 01/29/2013 | US8362058 Bicyclic compound, production and use thereof |
| 01/29/2013 | US8362031 Lonidamine analogues and treatment of polycystic kidney disease |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361485 Conditioned cell culture medium compositions and methods of use |
| 01/29/2013 | CA2525946C Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | WO2012163088A3 Medicine for treating kidney and heart disease and the uses thereof |
| 01/24/2013 | WO2012158942A9 Drug treatment of overactive bladder |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023546 Thienopyrimidine derivatives |
| 01/24/2013 | US20130023530 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023509 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023508 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023507 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130022695 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/23/2013 | EP2548890A1 Anti MIF antibodies |
| 01/23/2013 | EP2548562A1 Combination therapy with iron-based phosphate absorbers |
| 01/23/2013 | EP2547356A1 Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound |
| 01/23/2013 | EP2158900B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892423A Adiponectin production accelerating composition |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102887894A Crystal form of solifenacin succinate and preparation method thereof |
| 01/23/2013 | CN102887889A Heterocyclic substitute dpyrimidines |
| 01/23/2013 | CN102886028A Chinese herba preparation for treating dampness and hotness obstruction type chronic prostatitis |
| 01/23/2013 | CN102886021A Mongolian medicine for treating renal insufficiency |
| 01/23/2013 | CN102885955A Medicament for treating pulmonary actinomycosis infection after kidney transplantation operation |
| 01/23/2013 | CN102885954A Traditional Chinese medicine (TCM) for treating urinary tract infection (UTI) |
| 01/23/2013 | CN102885944A Pharmaceutical composition for treating recurrent cystitis |
| 01/23/2013 | CN102885925A Chinese medicinal preparation for treating deficiency of qi and blood, qi stagnation and blood stasis |
| 01/23/2013 | CN102885849A Use of biocompatible polymers for the preparation of a composition or a medical device |
| 01/23/2013 | CN102885831A Application of Gypensapogenin A in medicine for treating hemorrhagic fever with renal syndrome |
| 01/23/2013 | CN102885810A Candesartan cilexetil double-release capsule and preparation method thereof |
| 01/23/2013 | CN102885348A Medlar and mulberry beverage with kidney tonifying effect and preparation method thereof |
| 01/23/2013 | CN102885315A A lycogen composition for treating or preventing behign prostate hypertrophy or renal function diseases |
| 01/23/2013 | CN102885298A Litchi seed beverage for preventing and treating prostatic disease and preparation method thereof |
| 01/23/2013 | CN102327596B Chinese medicinal composition for treating urinary incontinence |
| 01/23/2013 | CN102210753B Traditional Chinese medicine composition for treating lithiasis in urinary system |
| 01/23/2013 | CN101816701B Process for preparing kudzu root extract instant grains |
| 01/23/2013 | CN101735918B Selenium-rich health wine and production method thereof |
| 01/23/2013 | CN101181540B Application of pharmaceutical composition in the preparation of medicine for prostatitis resistance |
| 01/22/2013 | US8357656 Natriuretic peptide receptor-C agonists |
| 01/22/2013 | US8357366 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/17/2013 | WO2013010100A1 Methods for treatment of incontinence associated with sexual activity |
| 01/17/2013 | WO2013009073A2 Composition comprising psoralea corylifolia l. extracts |
| 01/17/2013 | WO2013007557A1 Pharmaceutical composition, methods for treating and uses thereof |
| 01/17/2013 | WO2012156998A3 Amorphous mirabegron and processes for crystal forms of mirabegron |
| 01/17/2013 | US20130018084 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| 01/17/2013 | US20130018081 AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 01/17/2013 | US20130018055 New aryl-benzocycloalkyl amide derivatives |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018043 Aminomethyl quinolone compounds |
| 01/17/2013 | US20130018034 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors |
| 01/17/2013 | US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 01/17/2013 | US20130018017 Quinolinone derivatives as parp and tank inhibitors |
| 01/17/2013 | US20130018014 New class of therapeutics that enhance small molecule diffusion |
| 01/17/2013 | US20130017998 Novel modified galectin 9 proteins and use thereof |
| 01/17/2013 | US20130017600 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017172 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus |
| 01/17/2013 | US20130017150 Methods for prevention and treatment of acute renal injury |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2841917A1 Methods for treatment of incontinence associated with sexual activity |
| 01/17/2013 | CA2837787A1 Pharmaceutical composition, methods for treating and uses thereof |
| 01/16/2013 | EP2546255A1 Benzazepine compound |
| 01/16/2013 | EP2545929A1 Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
| 01/16/2013 | EP2545927A1 Adsorption carbon, and adsorbent |
| 01/16/2013 | EP2545925A1 Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases |
| 01/16/2013 | EP2545920A1 Therapy for complications of diabetes |
| 01/16/2013 | EP2545053A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 01/16/2013 | EP2545025A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | CN202666024U Kidney channel Chinese medicine injecta and package of the same |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884037A Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | CN102883733A AGE production inhibitor |
| 01/16/2013 | CN102883724A Use of meloxicam for the long-term treatment of kidney disorders in cats |
| 01/16/2013 | CN102875567A Piperazine compound and preparation and usage thereof |